Navigation Links
ER Wait Times Getting Longer
Date:1/15/2008

Even those needing most urgent care are waiting more, study finds,,,,

TUESDAY, Jan. 15 (HealthDay News) -- The last thing you want to hear in the emergency room when you've got crushing chest pain or can't breathe is that you have to wait before you can get treatment.

Unfortunately, in too many instances, that's exactly what's happening. In fact, new research found that waiting times in emergency rooms have increased by 36 percent for all patients, to an average of 30 minutes per patient. And the sickest sometimes have to wait the longest: As many as one-quarter of all heart attack patients had to wait 50 minutes or longer before seeing a doctor.

Study author Dr. Andrew Wilper, a fellow in general internal medicine at Harvard Medical School and an internist with the Cambridge Health Alliance, reports in the Jan. 15 online issue of Health Affairs that the increasing wait times are the result of a "perfect storm" that has occurred as emergency room visits are on the rise while many ERs are closing their doors.

"It's hard to ignore the fact that several hundred ERs have closed their doors, and we've seen an increase in the number of patients using ERs. Plus, there are a number of internal factors contributing like bottlenecks because of a lack of inpatient bed space and a lack of specialists available to treat patients," Wilper explained.

"The real problem is that patients are backing up in the ER. If a patient is still in the ER six or even 12 hours later, it means that room, that nurse and that equipment just aren't available for the next patient that comes in the door," explained Dr. Art Kellermann, a spokesman for the American College of Emergency Physicians.

Kellermann said a good analogy to this situation would be if controllers at a busy airport started parking planes on the runways. "We'd think they'd lost their minds, but that's what hospital administrations are doing with ERs," sai
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
2. Most Medicare Drug Plans Continue to Hike Costs into 2008 Two-to-Three Times Rate of Inflation
3. Light powered platinum more targeted and 80 times more powerful than similar cancer treatments
4. Study: Short sleep times in patients with chronic medical diagnoses linked to obesity
5. YOU: Staying Young Fourth New York Times Best-Seller for RealAge Test Creator Dr. Michael Roizen!
6. Louisiana Tech professor is Small Times Innovator of the Year
7. Statement from American Association for Homecare on New York Times Article about Home Oxygen Therapy
8. CQRC Statement on the NY Times Article on Medicares Home Oxygen Benefit
9. People overestimate their self-reported sleep times compared to measures by a sleep test
10. Prostate cancer increases hip fracture risk by eight times in 50 to 65 year-olds
11. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ER Wait Times Getting Longer
ER Wait Times Getting Longer
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Steven Mosher,...I), says that America has,a hidden problem of sex ...feminists refuse to address., In PRI,s latest You...,East and South Asian countries, of sex-selective ...actice has already claimed the lives of over 100,m...
(Date:7/24/2008)...July 24 /PRNewswire/ -- A new alliance of animal,l...roblems -- obesity -- in,pets and pet owners., Am...ne third of us are,obese, including 9 million chil...ok like us -- mirror us with similar health issues...partnership that includes,Harvard Medical Center, ...
(Date:7/24/2008)... CosmetaLife clinical trial results could lead ...cost-effective treatment for deep lines and wrinkl...inn. (PRWEB) July 24, 2008 -- Gel-Del Technologie...company announced that it has concluded clinical t...at company officials say holds potential to be a m...
(Date:7/24/2008)...RNewswire-FirstCall/ --, Key Highlights, Misys p...ns and is now,raising targets for the next phase o...) of GBP492m up 6%, bringing Group operating profi...xecuting on its strategy and entering,into the nex...m for growth., To view the Multimedia News Releas...
Breaking Medicine News(10 mins):Health News:PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4
...g blind and partially sighted people in the Lothia...e for the Blind (RNIB) received a ?25,000 donation...help in launching the charity's Positive Steps pro...ning for people preparing to enter employment. Th...
... for Type 2 Diabetes appears to have a twin benefi...ar under control// but also helps them to lose wei...n associate Professor with the Royal Prince Alfred...this drug has been under trial on patient voluntee...
... of teeth, do not improve the mental well being an...study//. Thousands of children have orthodontic wo...n the dental profession that braces or orthodontic...ll-being, reported the online edition of BBC News....
...cer deaths for the second consecutive year, the Am...can Health Challenge// to educate and motivate Ame... Many Americans are concerned about potentially d...t 50 percent of cancer deaths could be prevented t...
Other Medicine News:Health News:Healthy Behaviors Can Prevent at Least 50 Percent of Cancer Deaths 2
(Date:7/23/2008)...Dendreon Corporation,(Nasdaq: DNDN ) today announ...g Committee (IDMC) to review in October 2008 the i...e Company,s Phase 3 IMPACT (IMmunotherapy,for Pros...B) clinical trial,of PROVENGE(R) (sipuleucel-T). P...llular immunotherapy for the treatment of advanced...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
(Date:7/22/2008)...e to Patients of Passing a Follow-...ly 22 /- Insmed Inc. (Nasda... biopharmaceuticals, today,announced that Geoffrey...ngressional briefing on Friday, July 25th, 2008 to...approval pathway for follow-on,biologics (FOB) and...
(Date:7/22/2008)...re-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX) ...enrollment of 417 osteoarthritis (OA) patients wit...logy studies in the United States, in line with,pr...igned to assess the,blood pressure profile of napr...using the Ambulatory Blood Pressure Monitoring (AB...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 1Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 2Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 3Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 4Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 5Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 6Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 7Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 8Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 9Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 10Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 11Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 12Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 13Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 14Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 15Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 16Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 17Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 18Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 19Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 20Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 21Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 22Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 23Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 24Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 25AMA 3A NY Attorney General Actions Will Protect Patient Choice of Physicians 4124 1Massive reanalysis of genome data solves case of the lethal genes 1363 1Massive reanalysis of genome data solves case of the lethal genes 1363 2Breast Cancer Survivors and Their Supporters Sing to Live 4121 1Breast Cancer Survivors and Their Supporters Sing to Live 4121 2
...Northfield,Laboratories Inc. (Nasdaq: NFLD) announ...has informed the Company that the report of,the su... with,PolyHeme(R), the Company,s human-hemoglobin ...t be complete until May., About Northfield Laborat...n developing an,oxygen-carrying red blood cell sub...
...tic,benefits of adding Diovan to conventional ther...mes for,Diovan patients , , , BASEL,Switzerlan...dent,Jikei Heart Study, published today in The Lan...ng medication Diovan® to,conventional therapy ...r events and a 40% reduction in stroke. , , The ...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
The GENESIS II* Total Knee System will define the state of knee implants.
Cruciate Retaining, Posterior Stabilized and Constrained Components.
StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Medicine Products: